Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.003 AUD | 0.00% |
|
0.00% | -14.29% |
05-16 | Avecho Biotechnology Doses First Patient in Phase III Anti-Insomnia Drug Trial | MT |
03-25 | Avecho Biotechnology Begins Patient Recruitment for Phase Three Anti-Insomnia Drug Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-14.29% | 6.34M | |
+19.41% | 45.51B | |
+38.65% | 39.36B | |
-8.62% | 38.52B | |
+26.95% | 30.74B | |
-13.50% | 26.03B | |
+10.74% | 25.92B | |
+44.87% | 14.13B | |
+34.36% | 12.73B | |
-7.14% | 11.29B |
- Stock Market
- Equities
- AVE Stock
- News Avecho Biotechnology Limited
- Avecho Biotechnology Achieves Two-Year Stability Milestone for CBD Capsule